In this recent Pharma’s Almanac interview, Alpenglow CEO Nicholas Reder, M.D. explains the critical role of pathology in understanding the safety and efficacy of drugs and how Alpenglow is using a novel combination of 3D imaging, cloud computing & AI analysis to address the limitations associated with legacy approaches.